These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 9215596

  • 1. Involvement of cortical neurotensin in the regulation of rat meso-cortico-limbic dopamine neurons: evidence from changes in the number of spontaneously active A10 cells after neurotensin receptor blockade.
    Santucci V, Gueudet C, Steinberg R, Le Fur G, Soubrié P.
    Synapse; 1997 Aug; 26(4):370-80. PubMed ID: 9215596
    [Abstract] [Full Text] [Related]

  • 2. Stimulation by neurotensin of dopamine and 5-hydroxytryptamine (5-HT) release from rat prefrontal cortex: possible role of NTR1 receptors in neuropsychiatric disorders.
    Petkova-Kirova P, Rakovska A, Zaekova G, Ballini C, Corte LD, Radomirov R, Vágvölgyi A.
    Neurochem Int; 2008 Dec; 53(6-8):355-61. PubMed ID: 18835308
    [Abstract] [Full Text] [Related]

  • 3. Acute and chronic administration of the selective D(3) receptor antagonist SB-277011-A alters activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study.
    Ashby CR, Minabe Y, Stemp G, Hagan JJ, Middlemiss DN.
    J Pharmacol Exp Ther; 2000 Sep; 294(3):1166-74. PubMed ID: 10945873
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of A9 and A10 dopamine cells by the cholecystokinin-B antagonist LY262691: mediation through feedback pathways from forebrain sites.
    Rasmussen K, Howbert JJ, Stockton ME.
    Synapse; 1993 Oct; 15(2):95-103. PubMed ID: 8259526
    [Abstract] [Full Text] [Related]

  • 5. Acute and chronic administration of the selective 5-HT1A receptor antagonist WAY-405 significantly alters the activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study.
    Minabe Y, Schechter L, Hashimoto K, Shirayama Y, Ashby CR.
    Synapse; 2003 Dec 01; 50(3):181-90. PubMed ID: 14515335
    [Abstract] [Full Text] [Related]

  • 6. CI-943, a potential antipsychotic agent. III. Evaluation of effects on dopamine neuronal activity.
    Meltzer LT, Christoffersen CL, Heffner TG, Freeman AS, Chiodo LA.
    J Pharmacol Exp Ther; 1989 Oct 01; 251(1):123-30. PubMed ID: 2571714
    [Abstract] [Full Text] [Related]

  • 7. The acute and chronic administration of (+/-)-8-hydroxy-2-(Di-n-propylamino)tetralin significantly alters the activity of spontaneously active midbrain dopamine neurons in rats: an in vivo electrophysiological study.
    Nakamura K, Suzuki K, McCreary AC, Ashby CR.
    Synapse; 2006 May 01; 59(6):359-67. PubMed ID: 16463399
    [Abstract] [Full Text] [Related]

  • 8. Electrophysiological effects of BMY 14802, a new potential antipsychotic drug, on midbrain dopamine neurons in the rat: acute and chronic studies.
    Wachtel SR, White FJ.
    J Pharmacol Exp Ther; 1988 Jan 01; 244(1):410-6. PubMed ID: 2891845
    [Abstract] [Full Text] [Related]

  • 9. The neurotensin receptor antagonist SR 142948A blocks the efflux of dopamine evoked in nucleus accumbens by neurotensin ejection into the ventral tegmental area.
    Leonetti M, Brun P, Sotty F, Steinberg R, Soubrié P, Bert L, Renaud B, Suaud-Chagny MF.
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Jun 01; 365(6):427-33. PubMed ID: 12070755
    [Abstract] [Full Text] [Related]

  • 10. Neurotensin modulation of acetylcholine, GABA, and aspartate release from rat prefrontal cortex studied in vivo with microdialysis.
    Petkova-Kirova P, Rakovska A, Della Corte L, Zaekova G, Radomirov R, Mayer A.
    Brain Res Bull; 2008 Sep 30; 77(2-3):129-35. PubMed ID: 18721670
    [Abstract] [Full Text] [Related]

  • 11. Involvement of 5-HT1B receptors within the ventral tegmental area in ethanol-induced increases in mesolimbic dopaminergic transmission.
    Yan QS, Zheng SZ, Feng MJ, Yan SE.
    Brain Res; 2005 Oct 26; 1060(1-2):126-37. PubMed ID: 16212943
    [Abstract] [Full Text] [Related]

  • 12. Endogenous neurotensin attenuates dopamine-dependent locomotion and stereotypy.
    Chartoff EH, Szczypka MS, Palmiter RD, Dorsa DM.
    Brain Res; 2004 Oct 01; 1022(1-2):71-80. PubMed ID: 15353215
    [Abstract] [Full Text] [Related]

  • 13. Repeated administration of the neurotensin receptor antagonist SR 48692 differentially regulates mesocortical and mesolimbic dopaminergic systems.
    Azzi M, Betancur C, Sillaber I, Spanagel R, Rostène W, Bérod A.
    J Neurochem; 1998 Sep 01; 71(3):1158-67. PubMed ID: 9721741
    [Abstract] [Full Text] [Related]

  • 14. Endogenous neurotensin down-regulates dopamine efflux in the nucleus accumbens as revealed by SR-142948A, a selective neurotensin receptor antagonist.
    Brun P, Leonetti M, Sotty F, Steinberg R, Soubrié P, Renaud B, Suaud-Chagny MF.
    J Neurochem; 2001 Jun 01; 77(6):1542-52. PubMed ID: 11413237
    [Abstract] [Full Text] [Related]

  • 15. [Neurotensin receptor antagonists and therapeutical perspectives].
    Gully D, Maffrand JP, Soubrié P, Rostène W, Kitabgi P, Le Fur G.
    Therapie; 1995 Jun 01; 50(1):5-7. PubMed ID: 7754478
    [Abstract] [Full Text] [Related]

  • 16. Blockade of neurotensin receptor by SR 48692 potentiates the facilitatory effect of haloperidol on the evoked in vivo dopamine release in the rat nucleus accumbens.
    Brun P, Steinberg R, Le Fur G, Soubrié P.
    J Neurochem; 1995 May 01; 64(5):2073-9. PubMed ID: 7722490
    [Abstract] [Full Text] [Related]

  • 17. Neurotensin depolarizes globus pallidus neurons in rats via neurotensin type-1 receptor.
    Chen L, Yung KK, Yung WH.
    Neuroscience; 2004 May 01; 125(4):853-9. PubMed ID: 15120846
    [Abstract] [Full Text] [Related]

  • 18. Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonist.
    Gully D, Labeeuw B, Boigegrain R, Oury-Donat F, Bachy A, Poncelet M, Steinberg R, Suaud-Chagny MF, Santucci V, Vita N, Pecceu F, Labbé-Jullié C, Kitabgi P, Soubrié P, Le Fur G, Maffrand JP.
    J Pharmacol Exp Ther; 1997 Feb 01; 280(2):802-12. PubMed ID: 9023294
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Dose-dependent pain-facilitatory and -inhibitory actions of neurotensin are revealed by SR 48692, a nonpeptide neurotensin antagonist: influence on the antinociceptive effect of morphine.
    Smith DJ, Hawranko AA, Monroe PJ, Gully D, Urban MO, Craig CR, Smith JP, Smith DL.
    J Pharmacol Exp Ther; 1997 Aug 01; 282(2):899-908. PubMed ID: 9262357
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.